BWW Geeks World

Endocan Corporation XCHC Excited to Announce Launch of New Website and Corporate Brand Endocan on Thursday, October 17, 2013 to Further Advance Industry-Driven Branding t

October 14
10:43 2013
Endocan Corporation XCHC Excited to Announce Launch of New Website and Corporate Brand Endocan on Thursday, October 17, 2013 to Further Advance Industry-Driven Branding t

COLORADO SPRINGS, Colo., Oct. 14, 2013 /PRNewswire/ Endocan Corporation (NASDAQ OTC: XCHC) a U.S. Company specializing in cannabinoid formulation-based health and wellness solutions, is pleased to announce that the name change and the updated and revised Company website and corporate collateral package, will be released Thursday, October 17, 2013.

Endocan Corporation is creating an enhanced international brand and image with a blend of scientific expertise and patient orientated products to attack critical ailments and help promote an enhanced healthy autoimmune system to help maintain and regulate a strong healthy mind and body state with its proprietary cannabis based formulations and procedures.

Dr. Dorothy Bray, President & CEO, Endocan Corporation, stated, "We are on the cusp of our new product releases, designed for patients internationally. We will offer patients educational support and the opportunity of voluntary participation in our in-house tracking and anonymized data sharing systems through our new website noting patient feedback to improve future product development and new product release systems."

In the United States dispensary owners across the United States will be licensed to release the Company's brands and formulations for retail distribution through licensing agreements utilizing the Endocan brand name. In Canada the Company has an established network of professionals and regulatory experts to bring its products to market for patient use. Initially the Company will be releasing its formulations through several expert relationships across Canada. The Company has established two subsidiaries in The Netherlands, including Endocan B.V., for the Company's expanding European operations.

About Endocan Corporation

The brand name Endocan was chosen by the Board as a direct reference to the endocannabinoid system of the human body. The endocannabinoid system is a group of neuromodulatory compounds and their receptors that are involved in a variety of fundamental physiological processes including pain-sensation, immune function, stress, sleep, mood, appetite, and memory. Cannabinoids from plants, including those found in the Cannabis genus, as well as those autonomously produced within living biological systems, work together in the operation of the endocannabinoid system. The modulation of this system is the basis for cannabinoid-based medical treatments to assist patients to improve their health and well-being.

Related Links
2016 Scripps National Spelling Bee Declares Co-Champions2016 Scripps National Spelling Bee Declares Co-Champions
May 27, 2016
AT&T California And Statewide Electric Vehicle Collaborative Kick Off A Series Of Summer Ride-And-Drive Education Events To Help California Reach 250,000 EV MilestoneAT&T California And Statewide Electric Vehicle Collaborative Kick Off A Series Of Summer Ride-And-Drive Education Events To Help California Reach 250,000 EV Milestone
May 26, 2016
TrackX Holdings Inc.: Reverse Takeover CompletedTrackX Holdings Inc.: Reverse Takeover Completed
May 26, 2016
Tellza Announces Results of Shareholder MeetingTellza Announces Results of Shareholder Meeting
May 26, 2016
UniPixel Announces Public Offering of its Common StockUniPixel Announces Public Offering of its Common Stock
May 26, 2016


About Author

   Subscribe to Author Alerts

GEEKS VIDEOS



Become a Fan, Follower & Subscriber

           Facebook Like Follow